retatrutide phase 2 trial obesity nejm 2023 VisualAbstract: reduces body weight by 17.5% in patients with Triple hormone receptor agonist retatrutide
Pay in 4 interest-free payments of $5.77 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 12 - Aug 17




























